Page results
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
-
In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Education and training videos for Red Cell Network patients
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
Patient information for Red Cell Network patients
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
File results
-
FOI/2024/0061 - 24 hour waits at A&E from 2019 to 2023
-
FOI/2024/0063 - Clinicians and nurses trained in treating patients with sodium nitrite poisoning
-
FOI/2024/0064 - Communications and public relations spend for 2020/21-2022/23
-
FOI/2024/0066 - Amputations due to medical errors 2020-2023
-
FOI/2024/0070 - Treatments for metastatic/ adjuvant melanoma, colorectal and lung cancers
-
FOI/2024/0075 - Blood products used at Trust
-
FOI/2024/0076 - Patient Portal contract and supplier
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0079 - Water procurement
-
FOI/2024/0080 - Patient treatment for botched non-surgical procedures